13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$315.45B
+9.9% on the quarter before
Positions
415
25 new · 27 sold out
Top 10
27.0%
of the value
Est. gain
+$34.64B
on stocks held all quarter
Est. return
+13.2%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 46% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alibaba~$1.54BAdded · 0.9% → 1.6%+8,439,261 shares
- Vale Sa On ADR~$1.06BAdded · 0.7% → 1.0%+81,531,032 shares
- Freeport-McMoRan~$1.05BAdded · 0.2% → 0.6%+81,665,941 shares
- Micron~$738.5MNew · 0.0% → 0.2%+17,867,672 shares
- Exxon Mobil Corp~$565.6MAdded · 1.3% → 1.6%+7,000,222 shares
- PayPal~$452.7MNew · 0.0% → 0.1%+4,359,421 shares
- ServiceNow~$413.2MAdded · 0.4% → 0.6%+1,676,433 shares
- Linde Plc~$407.3MAdded · 0.7% → 0.8%+2,315,736 shares
- Gilead Sciences Inc~$366.5MAdded · 1.6% → 1.6%+5,637,146 shares
- General Mills Inc~$362.6MNew · 0.0% → 0.1%+7,007,470 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Abbvie Inc~$2.18BCut · 5.6% → 3.7%−27,059,898 shares
- Microsoft~$1.42BCut · 3.9% → 3.7%−12,069,287 shares
- Transcanada Corp~$1.37BSold out · 0.5% → 0.0%−38,497,012 shares
- Verizon Communications Inc~$1.36BCut · 1.8% → 1.3%−23,078,200 shares
- Amazon~$1.01BCut · 2.5% → 2.3%−564,976 shares
- Cbs Corp Cl B N/V~$900.6MCut · 0.5% → 0.2%−18,948,956 shares
- Broadcom~$858.5MCut · 2.2% → 2.1%−2,854,759 shares
- Twenty-First Century Fox Inc Cl A (Limited Voting)~$782.3MSold out · 0.3% → 0.0%−16,256,461 shares
- Alphabet~$621.2MCut · 1.8% → 1.7%−529,462 shares
- Abbott Laboratories~$508.2MCut · 3.1% → 2.9%−6,356,769 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MetaCOMMON STOCK · shares +2.7% · price +27.2% | 3.8% | $11.95B | +$2.48B | ||||||||
| Abbvie IncCOMMON STOCK · shares −16% · price −12.6% | 3.7% | $11.81B | −$1.70B | ||||||||
| MicrosoftCOMMON STOCK · shares −11% · price +16.1% | 3.7% | $11.53B | +$1.60B | ||||||||
| NetflixCOMMON STOCK · shares +3.7% · price +33.2% | 3.0% | $9.50B | +$2.28B | ||||||||
| Abbott LaboratoriesCOMMON STOCK · shares −5.2% · price +10.5% | 2.9% | $9.24B | +$879.5M | ||||||||
| AmazonCOMMON STOCK · shares −12% · price +18.6% | 2.3% | $7.37B | +$1.15B | ||||||||
| BroadcomCOMMON STOCK · shares −11% · price +18.3% | 2.1% | $6.74B | +$1.04B | ||||||||
| Amgen IncCOMMON STOCK · shares −5.0% · price −2.4% | 2.0% | $6.34B | −$156.6M | ||||||||
| AlphabetCOMMON STOCK · shares −10% · price +13.3% | 1.7% | $5.35B | +$628.4M | ||||||||
| IntelCOMMON STOCK · shares +0.7% · price +14.4% | 1.7% | $5.28B | +$660.8M | ||||||||
| AlphabetCOMMON STOCK · shares −8.8% · price +12.6% | 1.6% | $5.16B | +$578.4M | ||||||||
| AlibabaCOMMON STOCK · shares +43% · price +33.1% | 1.6% | $5.10B | +$885.3M | ||||||||
| Gilead Sciences IncCOMMON STOCK · shares +7.8% · price +3.9% | 1.6% | $5.08B | +$178.5M | ||||||||
| Exxon Mobil CorpCOMMON STOCK · shares +13% · price +18.5% | 1.6% | $5.04B | +$698.9M | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares −7.4% · price +32.4% | 1.4% | $4.49B | +$1.10B | ||||||||
| Eog Resources IncCOMMON STOCK · shares +1.9% · price +9.1% | 1.4% | $4.44B | +$364.5M | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −7.1% · price −0.7% | 1.4% | $4.42B | −$33.2M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −25% · price +5.2% | 1.3% | $4.09B | +$201.5M | ||||||||
| MastercardCOMMON STOCK · shares −2.1% · price +24.8% | 1.3% | $4.08B | +$811.5M | ||||||||
| Thermo Fisher Scientific IncCOMMON STOCK · shares −7.9% · price +22.3% | 1.3% | $4.01B | +$732.3M | ||||||||
| General Dynamics CorpCOMMON STOCK · shares +2.9% · price +7.7% | 1.2% | $3.91B | +$270.9M | ||||||||
| Altria Group IncCOMMON STOCK · shares +0.6% · price +16.3% | 1.2% | $3.79B | +$527.3M | ||||||||
| Lowes Companies IncCOMMON STOCK · shares −1.6% · price +18.5% | 1.1% | $3.62B | +$565.6M | ||||||||
| Nike Inc Cl BCOMMON STOCK · shares −12% · price +13.6% | 1.1% | $3.49B | +$417.9M | ||||||||
| Csx CorpCOMMON STOCK · shares +3.3% · price +20.4% | 1.0% | $3.25B | +$533.2M | ||||||||
| Total · 415 positions | 100% | $315.45B | +$34.64B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 383 stocks held throughout, up $34.64B (+13.2%).
- Meta+$2.48B+27%
- Netflix+$2.28B+33%
- Microsoft+$1.60B+16%
- Amazon+$1.15B+19%
- Philip Morris International+$1.10B+32%
- Herbalife Nutrition Ltd−$94.3M−10%
- Amgen Inc−$156.6M−2%
- Cigna Corp−$246.2M−15%
- Cme Group Inc Cl A−$268.7M−13%
- Abbvie Inc−$1.70B−13%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |